Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco Acin

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
International Journal of Cardiology|January 8, 2017
Nuclear factor-kappa B role in NLRP1 inflammasome activation by triglycerides and VLDL cholesterol in endothelial cellsSilvia Bleda, Joaquin De Haro, Francisco Acin
International Journal of Cardiology|November 29, 2015
The need for carefully reading. Time matters!Joaquin De Haro, Silvia Bleda, Francisco Acin
International Journal of Cardiology|October 12, 2015
C-reactive protein predicts aortic aneurysmal disease progression after endovascular repairJoaquin De Haro, Silvia Bleda, Francisco Acin
International Journal of Cardiology|September 14, 2014
An open-label study on long-term outcomes of bosentan for treating ulcers in thromboangiitis obliterans (Buerger's disease)Joaquin De Haro, Silvia Bleda, Francisco Acin
International Journal of Cardiology|September 17, 2017
Statin potential Nlrp1 inflammasome gene expression modulation via Srebp-1 pathway in peripheral arterial diseaseSilvia Bleda, Joaquin de Haro, Francisco Acin
Annals of Vascular Surgery|July 20, 2010
Relationship between endothelial dependent vasodilation and size of abdominal aortic aneurysmsFrancisco Medina, Joaquin de Haro, Aurora Florez, et al.
Interactive Cardiovascular and Thoracic Surgery|May 24, 2012
Non-Fas(CD95/APO1)-mediated apoptosis of activated T cells inhibits the development of atherosclerosisLeticia Esparza, Joaquin De Haro, Silvia Bleda, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 27, 2015
C-reactive protein and endovascular treatment of lower limb peripheral artery disease: an independent prognostic factorSilvia Bleda, Joaquin de Haro, Cesar Varela, et al.
BMJ Case Reports|June 21, 2011
Treatment of Buerger disease (thromboangiitis obliterans) with bosentan: a case reportJoaquin De Haro, Aurora Florez, Jose Luis Fernandez, et al.
BMC Cardiovascular Disorders|February 16, 2012
Treatment of thromboangiitis obliterans (Buerger's disease) with bosentanJoaquin De Haro, Francisco Acin, Silvia Bleda, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|January 8, 2017
Nuclear factor-kappa B role in NLRP1 inflammasome activation by triglycerides and VLDL cholesterol in endothelial cellsSilvia Bleda, Joaquin De Haro, Francisco Acin
International Journal of Cardiology|November 29, 2015
The need for carefully reading. Time matters!Joaquin De Haro, Silvia Bleda, Francisco Acin
International Journal of Cardiology|October 12, 2015
C-reactive protein predicts aortic aneurysmal disease progression after endovascular repairJoaquin De Haro, Silvia Bleda, Francisco Acin
International Journal of Cardiology|September 14, 2014
An open-label study on long-term outcomes of bosentan for treating ulcers in thromboangiitis obliterans (Buerger's disease)Joaquin De Haro, Silvia Bleda, Francisco Acin
International Journal of Cardiology|September 17, 2017
Statin potential Nlrp1 inflammasome gene expression modulation via Srebp-1 pathway in peripheral arterial diseaseSilvia Bleda, Joaquin de Haro, Francisco Acin
Annals of Vascular Surgery|July 20, 2010
Relationship between endothelial dependent vasodilation and size of abdominal aortic aneurysmsFrancisco Medina, Joaquin de Haro, Aurora Florez, et al.
Interactive Cardiovascular and Thoracic Surgery|May 24, 2012
Non-Fas(CD95/APO1)-mediated apoptosis of activated T cells inhibits the development of atherosclerosisLeticia Esparza, Joaquin De Haro, Silvia Bleda, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 27, 2015
C-reactive protein and endovascular treatment of lower limb peripheral artery disease: an independent prognostic factorSilvia Bleda, Joaquin de Haro, Cesar Varela, et al.
BMJ Case Reports|June 21, 2011
Treatment of Buerger disease (thromboangiitis obliterans) with bosentan: a case reportJoaquin De Haro, Aurora Florez, Jose Luis Fernandez, et al.
BMC Cardiovascular Disorders|February 16, 2012
Treatment of thromboangiitis obliterans (Buerger's disease) with bosentanJoaquin De Haro, Francisco Acin, Silvia Bleda, et al.
Pageof 4